ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Funding for New Construction At Georgetown, Yale

June 3, 1977

PET/CT Imaging During Treatment Shows Whether Chemo Is Working, Study Finds

April 24, 2009

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

Senate Appropriations Report Language On NCI, NIH Budgets

September 20, 1996

Coalitions Urges Members To Call, Write, Congress

May 3, 1991

Survey Show Better Understanding Of Breast Cancer

December 12, 1980